The current investigation elucidated that CEBPD serves as an upstream regulatory factor for key genes, including MYC, IL6, JUN, RRM2, and VEGFA, all of which have been linked to an unfavorable prognosis in cervical cancer patients. This evidence concerns the gene VEGFA and cervical cancer.